A perioperative study of safusidenib in patients with IDH1 mutated glioma

被引：0

作者：

Whittle, J. R. ^{[1
]}

Rosenthal, M. ^{[1
]}

Spiteri, M. ^{[2
]}

Cain, S. ^{[3
]}

Topp, M. D. ^{[1
]}

Shaya, S. ^{[1
]}

Jones, J. ^{[3
]}

Valkovic, A. ^{[2
]}

Fatunla, O. ^{[2
]}

Dimou, J.

Tobler, R. ^{[2
]}

Roberts-Thomson, S. ^{[4
]}

McArdle, D. ^{[5
]}

Lui, E. ^{[5
]}

Nijagal, B. ^{[6
]}

Grimmond, S. M. ^{[7
]}

Best, S. A. ^{[2
]}

Freytag, S. ^{[2
]}

Drummond, K. ^{[3
]}

机构：

[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia

[2] WEHI Walter & Eliza Hall Inst Med Res, Personalised Oncol, Parkville, Vic, Australia

[3] Royal Melbourne Hosp, Neurosurg, Melbourne, Vic, Australia

[4] Royal Melbourne Hosp, Anat Pathol, Melbourne, Vic, Australia

[5] Royal Melbourne Hosp, Radiol, Melbourne, Vic, Australia

[6] Bio21, Metabolom, Melbourne, Vic, Australia

[7] Univ Melbourne, Ctr Canc Res, Ctr Canc Res UMCCR, Victorian Comprehens Canc Ctr, Parkville, Vic, Australia

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.513

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

443O

引用

页码：S407 / S407

页数：1

共 50 条

[1] A PERIOPERATIVE STUDY OF SAFUSIDENIB IN PATIENTS WITH IDH1 MUTATED GLIOMA
Whittle, James
Rosenthal, Mark
Spiteri, Montana
Tobler, Robert
Topp, Monique
Cain, Sarah
Jones, Jordan
Shaya, Sammy
Valkovic, Adam
Fatunla, Oluwaseun
Dimou, James
Roberts-Thomson, Samuel
Mcardle, David
Lui, Elaine
Nijagal, Brunda
Mitchell, Camilla
Grimmond, Sean
Best, Sarah
Freytag, Saskia
Drummond, Kate
NEURO-ONCOLOGY, 2024, 26
[2] A perioperative study of Safusidenib in patients with IDH1-mutated glioma
Cain, Sarah A.
Topp, Monique
Rosenthal, Mark
Tobler, Robert
Freytag, Saskia
Best, Sarah A.
Whittle, James R.
Drummond, Katharine J.
FUTURE ONCOLOGY, 2024, 20 (33) : 2533 - 2545
[3] Mutant IDH1 and seizures in patients with glioma
Chen, Hao
Judkins, Jonathon
Thomas, Cheddhi
Wu, Meijing
Khoury, Laith
Benjamin, Carolina G.
Pacione, Donato
Golfinos, John G.
Kumthekar, Priya
Ghamsari, Farhad
Chen, Li
Lein, Pamela
Chetkovich, Dane M.
Snuderl, Matija
Horbinski, Craig
NEUROLOGY, 2017, 88 (19) : 1805 - 1813
[4] Ivosidenib in the treatment of patients with IDH1 mutated cholangiocarcinoma
Chmielewska, Agnieszka
Kubiatowski, Tomasz
ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (04): : 286 - 290
[5] Mutant IDH1 is required for IDH1 mutated tumor cell growth
Jin, Genglin
Pirozzi, Christopher J.
Chen, Lee H.
Lopez, Giselle Y.
Duncan, Christopher G.
Feng, Jie
Spasojevic, Ivan
Bigner, Darell D.
He, Yiping
Yan, Hai
ONCOTARGET, 2012, 3 (08) : 774 - 782
[6] IDH1 MUTATION ANALYSIS IN PEDIATRIC GLIOMA PATIENTS
Adachi, Jun-ichi
Suzuki, Tomonari
Fukuoka, Kohei
Yanagisawa, Takaaki
Mishima, Kazuhiko
Koga, Tomoyuki
Matsutani, Masao
Nishikawa, Ryo
NEURO-ONCOLOGY, 2012, 14 : 8 - 8
[7] Detection of IDH1 mutation in the plasma of glioma patients
Boisselier, Blandine
Labussiere, Marianne
Rossetto, Marta
Larraya, Jaime Gallego Perez
Marie, Yannick
Delattre, Jean-Yves
Sanson, Marc
CANCER RESEARCH, 2012, 72
[8] DETECTION OF IDH1 MUTATION IN THE PLASMA OF PATIENTS WITH GLIOMA
Rossetto, M.
Perez-Larraya, J. Gallego
Boisselier, B.
Ciccarino, P.
Labussiere, M.
Marie, Y.
Delattre, J.
Sanson, M.
NEURO-ONCOLOGY, 2012, 14 : 28 - 29
[9] Detection of IDH1 mutation in the plasma of patients with glioma
Boisselier, Blandine
Perez-Larraya, Jaime Gallego
Rossetto, Marta
Labussiere, Marianne
Ciccarino, Pietro
Marie, Yannick
Delattre, Jean-Yves
Sanson, Marc
NEUROLOGY, 2012, 79 (16) : 1693 - 1698
[10] PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma
Mohan, Arathi
Quingalahua, Elit
Gunchick, Valerie
Paul, Simi
Kumar-Sinha, Chandan
Crysler, Oxana
Zalupski, Mark M.
Sahai, Vaibhav
ONCOLOGIST, 2024, 29 (08): : 725 - 730

← 1 2 3 4 5 →